Loading clinical trials...
Loading clinical trials...
Efficacy of Thymoquinone as an Adjuvant Treatment With Pregabalin for the Treatment of Neuropathy in Diabetic Patients: A Randomized Clinical Trial of 65 mg of Thymoquinone and 75 mg Pregabalin Daily for Two Months
Conditions
Interventions
stander treatment pregabalin
thymoquinone
Locations
1
Iraq
Hawler medical university, Galyawa diabetic center and Neurophysiology department of hawler psychiatric hospital
Erbil, IRAQ, Iraq
Start Date
July 1, 2024
Primary Completion Date
September 1, 2025
Completion Date
September 1, 2025
Last Updated
December 31, 2025
NCT07128836
NCT00726713
Lead Sponsor
Hawler Medical University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions